维普中文期刊产品整合服务
18篇 您的检索式:作者名="Ansquer C"
    题名 作者 年代 出处 被引量
1Fibrates and statins in the treatment of diabetic retinopathy显示文摘ANSQUER J C CRIMET D FOUCHER C 2011Curr Pharm Biotechn- ol2011,12,3:1
2Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo controlled study in type 2 diabetes:results from the Diabetes Atherosclerosis Intervention Study (DAIS) 显示文摘Ansquer JC Foucher C Rattier S 2005Am J Kidney Dis2005,45,3:1
3Fenofibrate reduces progression to microalbuminuria over 3 years in a placebocontrolled study in type 2 diabetes:results from the Diabetes Atherosclerosis Intervention Study (DAIS)显示文摘ANSQUER J C FOUCHER C RATHER S 2005American Journal of Kidney Diseases2005,45,3:1
4Fenofibrate reducesprogression to microalbuminuria over 3 years in a placebocontrolleddstuay in type 2 diabetes:results from the Diabetes Atherosclerosis Intervention Study (DAIS)显示文摘Ansquer JC Foucher C Rattier S et al 2005Am J Kiadney Dis2005,45,3:1
5lS FFDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective muhicentre evaluation显示文摘Ansquer C Scigliano S Mirallie E 2010Eur J Nucl Med Mol Imaging2010,37,9:1
6Fenofibrate reduces pro- gression to miem-albuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atheroselerosis Intervention Study (DAIS) 显示文摘Ansquer JC Foueher C Rattier S 2005Am J Kidney Dis2005,45,3:1
7Proximal tubal occlusion: is thette an alternative to microsurgery? 显示文摘Dubuisson JB Chapron C Ansquer Y 1977Hum Reprod1977,12,4:1
8Fenofibrate, homocysteine and renal function显示文摘Foucher C Brug re L Ansquer J C 2010Curr Vasc Pharmacol2010,8,5:1
9Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes :results from the Diabetes Atheroselerosis Intervention Study (DAIS)显示文摘Ansquer JC Foucher C Rattier S 2005Am J Kidney Dis2005,45,48:1
10Is total laparoscopic hysterectomy a safe surgical procedure 显示文摘CHAPRON C DUBUISSON JB ANSQUER Y 1996Hum Reprod1996,11,:1
11Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)显示文摘Ansquer JC Foucher C Rattier S 2005American Journal of Kidney Diseases2005,45,3:1
12Fibrates and statins in the treatment of diabetic retinopathy显示文摘Ansquer JC Crimet D Foucher C 2011Curr Pharm Biotechnol2011,12,:1
13Relationships between low-density lipoprotein particle size,plasma lipoproteins,and progression of coronary artery disease:the Diabetes Atherosclerosis Intervention Study (DAIS)显示文摘Vakkilainen J Steiner G Ansquer JC Aubin F Rattier S Foucher C 2003Circulation2003,107,17:1
14Pre-targeted radioimmunotherapy(pRAIT)in medullary thy-roid cancer(MTC)显示文摘Kraeber-Bodere F Salaun PY Ansquer C 2012Tumour Biol2012,33,3:1
15Fenofibrate reduces progres- sion to mieroalbuminuria over 3 years in a placebo controlled study in type 2 diabetes: results from the Diabetes Atheroselerosis Interven- tion Study (DAIS) 显示文摘Ansquer J Foucher C Rattier S 2005Am J Kidney Dis2005,,45:1
16Fibrates and microvascular complications in diabetes--insight from the FIELD study显示文摘Ansquer JC Foucher C Aubonnet P 2009Curr Pharm Des2009,15,5:1
17Fenofibrate reduces progression to microalbuminuria over 3 years in a placebocontrolled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS) 显示文摘Ansquer JC Foucher C Rattier S 2005Am J Kidney Dis2005,45,3:1
18Lobular intra-epithelial neoplasia: atypical lobular hyperplasia and lobular carcinoma in situ显示文摘Ansquer Y Santulli P Colas C 2010J Gynecol Obstet Biol Reprod (Paris)2010,39,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费